TY - JOUR T1 - Clonidine was effective for reducing tamoxifen associated hot flashes in postmenopausal women with breast cancer JF - Evidence Based Medicine JO - Evid Based Med SP - 18 LP - 18 DO - 10.1136/ebm.6.1.18 VL - 6 IS - 1 A2 - , Y1 - 2001/01/01 UR - http://ebm.bmj.com/content/6/1/18.abstract N2 - (2000) Ann Intern Med 132, 788. Pandya KJ, Raubertas RF, Flynn PJ. , et al.. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program Study.. May 16;. :. –93. .OpenUrlPubMedWeb of Science
 
 QUESTION: In postmenopausal women receiving tamoxifen for breast cancer, does clonidine reduce hot flashes? Randomised {allocation concealed*}†, blinded {clinicians, patients, and outcome assessors}†,* placebo controlled trial with 12 weeks follow up. University of Rochester Cancer Center Community Clinical Oncology Program, New York, United States. 198 postmenopausal women who had received adjuvant tamoxifen treatment for breast cancer for ≥1 month and who reported ≥1 hot flash per day. Exclusion criteria were concurrent chemotherapy or other endocrine treatment for breast cancer; use of antihypertensive drugs, monoamine oxidase inhibitors, L-dopa, piribedil, tricyclic antidepressants, or sedatives; coronary insufficiency; myocardial infarction in the previous 3 months; symptomatic cardiac disease; peripheral or cerebrovascular disease; syncope; symptomatic hypertension; inability to tolerate clonidine; or abnormal renal or hepatic function. 194 women provided baseline data (mean age 54 y). Follow up was 91% at week 4, … ER -